Compositions for treatment of disorders of the oesophagus
The invention resides in a pharmaceutical composition and its use, the pharmaceutical composition comprising: a) 1 to 10 parts by weight of alginate, the alginate being a monovalent salt; b) 0.01 to 1.5 parts by weight of gum selected from xanthan gum, carageenan gum and mixtures thereof; and c) 0.0...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention resides in a pharmaceutical composition and its use, the pharmaceutical composition comprising: a) 1 to 10 parts by weight of alginate, the alginate being a monovalent salt; b) 0.01 to 1.5 parts by weight of gum selected from xanthan gum, carageenan gum and mixtures thereof; and c) 0.01 to 1.5 parts by weight of gum selected from a galactomannan, a glucomannan and mixtures thereof. The use is for the treatment and/or prevention of irritation and/or lesions in the oesophagus, diseases and/or irritations of the mouth, throat, pharynx and/or stomach and/or other diseases caused by or associated with reflux. |
|---|